AlphaWire

english_primary_news

In Med Pharmaceuticals Inc. filed an 8-K with the SEC

2026-07-22·english-primary-news-222801-01-sec_8k
In Med Pharmaceuticals Inc. filed an 8-K with the SEC.

According to a filing posted on the U.S. Securities and Exchange Commission's EDGAR system:

Primary filing notice from SEC EDGAR.

Filed: 2026-07-22 AccNo: 0001213900-26-080414 Size: 303 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

#Stocks #Markets

Full text

In Med Pharmaceuticals Inc. filed an 8-K with the SEC

Primary filing notice from SEC EDGAR. Filed: 2026-07-22 AccNo: 0001213900-26-080414 Size: 303 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Primary filing notice from SEC EDGAR. Filed: 2026-07-22 AccNo: 0001213900-26-080414 Size: 303 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

← Back to archive